US SB2478 | 2017-2018 | 115th Congress
Status
Spectrum: Slight Partisan Bill (Democrat 3-1)
Status: Introduced on March 1 2018 - 25% progression, died in committee
Action: 2018-03-01 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on March 1 2018 - 25% progression, died in committee
Action: 2018-03-01 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Summary
End Taxpayer Subsidies for Drug Ads Act This bill amends the Internal Revenue Code to prohibit tax deductions for expenses relating to direct-to-consumer advertising of prescription drugs. "Direct-to-consumer advertising" is any dissemination, by or on behalf of a sponsor of a prescription drug product, of an advertisement that is: (1) in regard to the drug product, and (2) primarily targeted to the general public.
Title
End Taxpayer Subsidies for Drug Ads Act
Sponsors
| Sen. Claire McCaskill [D-MO] | Sen. Jeanne Shaheen [D-NH] | Sen. Sherrod Brown [D-OH] | Sen. Angus King [I-ME] |
History
| Date | Chamber | Action |
|---|---|---|
| 2018-03-01 | Senate | Read twice and referred to the Committee on Finance. |
Same As/Similar To
HB1776 (Related) 2017-04-05 - Referred to the Subcommittee on Health.
SB771 (Related) 2017-03-29 - Read twice and referred to the Committee on Finance.
SB3411 (Related) 2018-09-05 - Read twice and referred to the Committee on Finance.
SB771 (Related) 2017-03-29 - Read twice and referred to the Committee on Finance.
SB3411 (Related) 2018-09-05 - Read twice and referred to the Committee on Finance.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/115th-congress/senate-bill/2478/all-info |
| Text | https://www.congress.gov/115/bills/s2478/BILLS-115s2478is.pdf |
